0001707597-20-000001.txt : 20201007 0001707597-20-000001.hdr.sgml : 20201007 20201006205330 ACCESSION NUMBER: 0001707597-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201007 DATE AS OF CHANGE: 20201006 EFFECTIVENESS DATE: 20201007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Koligo Therapeutics, Inc. CENTRAL INDEX KEY: 0001707597 IRS NUMBER: 811717874 STATE OF INCORPORATION: KY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-377285 FILM NUMBER: 201227936 BUSINESS ADDRESS: STREET 1: 204 SOUTH FLOYD ST. CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5022425890 MAIL ADDRESS: STREET 1: 204 SOUTH FLOYD ST. CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: Koligo Therapeutics Inc. DATE OF NAME CHANGE: 20170525 D 1 primary_doc.xml X0708 D LIVE 0001707597 Koligo Therapeutics, Inc. 2113 State Street New Albany IN INDIANA 47150 5022654830 KENTUCKY Koligo Therapeutics Inc. Corporation true Matthew Lehman 2113 State Street New Albany IN INDIANA 47150 Executive Officer Biotechnology $1,000,001 - $5,000,000 06b false 2020-09-25 false true false 20000 1646759 1646759 0 false 2 0 0 0 false Koligo Therapeutics, Inc. Matthew Lehman Matthew Lehman CEO 2020-10-06